tofacitinib citrate - XELJANZ ( pronounced zel-jans ) is the first in a new class of treatments for moderate to severe RA. Called a Janus-associated kinase (JAK) inhibitor, it helps to reduce common RA symptoms such as joint pain, swelling, and stiffness.
Serious infections. XELJANZ can lower the ability of your immune system to fight infections. Some people have serious infections while taking XELJANZ, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting XELJANZ, and monitor you closely for signs and symptoms of TB infection during treatment. You should not start taking XELJANZ if you have any kind of infection unless your healthcare provider tells you it is okay.
Before starting XELJANZ, tell your healthcare provider if you:
I’ll pass.
Not a hair on my head (thanks Dad!) but I’m with you. Furthermore, the drug’s ability to do this for this young man probably has nothing to do with the good ol’ fashioned cause of male baldness, so I imagine it’s useless in that regard.